CROI 2016 Program at a Glance

Program and Agenda


Room 304/306

Session OS




2:15 PM-4:00 PM Interactive Case-BasedWorkshop on Hepatitis C Target audience: This session is directed to persons interested in the management of hepatitis C virus (HCV) infection. Level of knowledge: It is assumed that participants are familiar with the general principles of HCV treatment and the medications used. Objectives: At completion of the session, participants will be able to: • Describe the diagnosis and staging of patients with HCV infection • Describe the effective treatment of HCV infection according to HCV genotype and state of liver disease • Recognize how treatment differs for persons with cirrhosis Conveners Susanna Naggie, DukeUniversitySchool ofMedicine,Durham,NC,USA David L. Wyles, UniversityofCalifornia SanDiego,SanDiego,CA,USA

5:00 PM-7:00 PM Opening Session Opening Session Hosts Julie M. Overbaugh, FredHutchinsonCancerResearch CROI 2016 Chair Center,Seattle,WA,USA Susan P. Buchbinder SanFranciscoDepartmentofPublic CROI 2016 Vice Chair Health,SanFrancisco,CA,USA

Monday, February 22, 2016 • Oral Sessions

Judith S. Currier, DavidGeffenSchoolofMedicineat CROI 2016 Vice Chair UniversityofCaliforniaLosAngeles, LosAngeles,CA,USA

Bernard Fields Lecture The Bernard Fields Lecture, named in tribute to the exemplary work of the esteemed microbiologist and virologist Bernard Fields, is given during the Opening Session, usually by a basic scientist recognized for his or her important and relevant contributions to the fields of virology and viral pathogenesis. 13 T Cell Control of HIV: Implications for Vaccines and Cure Bruce D.Walker ,Ragon InstofMGH,MIT,and Harvard,Cambridge,MA,USA N’Galy-Mann Lecture The N’Galy-Mann Lecture recognizes an HIV/AIDS researcher for his or her important and relevant work in the fields of epidemiology or clinical research. The Lecture is named in honor of Drs Bosenge N’Galy and Jonathan Mann for their crucial, pioneering work in HIV science in Africa. 14 Confronting HIV and TB From the Bronx, NY, to Tugela Ferry, South Africa Gerald H. Friedland ,YaleUniversitySchoolofMed, NewHaven,CT,USA CROI Foundation Special Event A unique programming segment that will honor achievement, inform, and surprise. It should not be missed.

9 Treatment for HCV Genotype 1-Infected Patients With HIV/HCV Coinfection Anne F. Luetkemeyer ,UnivofCaliforniaSan Francisco,SanFrancisco,CA,USA 10 Treatment for Cirrhotic HCV Genotype 3-Infected Patients With Prior Treatment Failure Karine LaCombe ,SorbonneUnivs,Paris,France 11 HCV Infection Treatment Before and After Liver Transplant Elizabeth C.Verna ,ColumbiaUniv,NewYork, NY,USA 12 Treatment of HCV Infection in Groups at High Risk for Reinfection Oluwaseun Falade-Nwulia , JohnsHopkinsUniv, Baltimore,MD,USA

Fighting AIDS With Style Kenneth Cole ,KennethColeProductions, Inc,and Chairmanof theBoardofamfAR


CROI 2016

Made with FlippingBook HTML5